Literature DB >> 330825

Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.

R B Godwin-Austen, N J Smith.   

Abstract

The effects of bromocriptine and levodopa were compared in a blind trial in 18 patients with Parkinson's disease. Optimal doses of the two drugs were given in identical capsules: there was no significant difference between the therapeutic effects. There were wide individual differences in response to the two drugs. Side effects were more common with bromocriptine because of side effects.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 330825      PMCID： PMC492723          DOI： 10.1136/jnnp.40.5.479

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  3 in total

1.  Bromocriptine in Parkinsonism.

Authors:  D B Calne; P F Teychenne; L E Claveria; R Eastman; J K Greenacre; A Petrie
Journal:  Br Med J       Date:  1974-11-23

2.  Effects of L-dopa in Parkinson's disease.

Authors:  R B Godwin-Austen; E B Tomlinson; C C Frears; H W Kok
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

3.  Bromocriptine treatment in Parkinson's disease.

Authors:  J D Parkes; C D Marsden; I Donaldson; A Galea-Debono; J Walters; G Kennedy; P Asselman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-02       Impact factor: 10.154
  3 in total
  5 in total

1.  Audit of the drug treatment of Parkinson's disease in general practice.

Authors:  J A Wilson; T S Murray
Journal:  J R Coll Gen Pract       Date:  1985-06

Review 2.  Bromocriptine in the treatment of parkinsonism.

Authors:  J D Parkes
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 3.  Bromocriptine in Parkinsonism.

Authors:  I Pearce; J M Pearce
Journal:  Br Med J       Date:  1978-05-27

4.  Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.

Authors:  K Jellinger
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

Review 5.  Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Authors:  Sumit Sarkar; James Raymick; Syed Imam
Journal:  Int J Mol Sci       Date:  2016-06-08       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.